Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Pharma

COVID-19 vaccines require innovative approaches to achieve best balance of safety and efficacy

At present, more than 200 prophylactic vaccines are in development for COVID-19. While promising candidates should be selected for diversity, the novel nature of SARS-CoV-2 requires innovative approaches to achieve the best balance of safety and efficacy, says GlobalData, a leading data and analytics company. Mohamed Abukar, MSc, Clinical Trials Analyst at GlobalData, comments: “AstraZeneca’s AZD-1222 […]
Read more

Biotech IPO deals not slowing during COVID-19

Biotech company initial public offering (IPO) valuations have shown resilience during the COVID-19 pandemic, compared to other industries. This is largely due to the unique nature of pharmaceuticals and the industry’s role in developing a COVID-19 drug, as well as drugs for other serious medical needs, says GlobalData, a leading data and analytics company. Sharon […]
Read more

Oncology remains market-leading therapy area with $142bn sales in 2019

In a global prescription drug market worth over $600bn, oncology has become the dominant area, claiming a market share of 23.4% as of 2019, followed by immunology at 12.4% and metabolic disorders at 10.8% according to GlobalData, a leading data and analytics company. GlobalData’s analysis of a proprietary dataset shows that global drug sales with […]
Read more

Trilaciclib’s regulatory advancement signals a significant moment for supportive cancer care, says GlobalData

Trilaciclib’s new drug application (NDA) acceptance signals a significant moment for cancer patients that need support with chemotherapy-induced toxicities – further highlighted by the fact that the therapy has been granted Breakthrough Therapy Designation by the US FDA. By being able to preserve bone marrow and immune system function, Trilaciclib’s mechanism of action (MoA) of […]
Read more

US telemedicine mobile app downloads see dramatic increases during the COVID-19 pandemic, with some seeing 8,270% rise YoY, says GlobalData

Telemedicine looks to be here to stay as leading companies in this space have reported dramatic increases in demand for their services in the US since the COVID-19 pandemic began, according to GlobalData, a leading data and analytics company. Some of the biggest benefiters have been the Synzi Virtual Care app for physicians, which saw […]
Read more

BioMarin’s Valrox’s FDA rejection is a blow to severe hemophilia A patients in the US

Following the recent news that BioMarin received a Complete Response Letter (CRL) from the Food and Drug Administration (FDA) indicating that its gene therapy for severe hemophilia A, ValRox (valoctocogene roxaparvovec), was not yet ready for approval; Tajekesa Chapman, Senior Pharma Analyst at GlobalData, a leading data and analytics company, offers her view: “ValRox was expected to be the first-to-market hemophilia gene therapy and BioMarin had set its hopes on launching the product this year. However, the FDA has recommended evidence of durability with two years of follow-up safety and efficacy data, and so delaying launch to 2022. The introduction of gene therapies […]
Read more

Following FDA-issued CRL, head-to-head trial necessary strategy for Gilead and Galapagos’ filgotinib, says GlobalData

Gilead received a big shock following the FDA’s complete response letter (CRL) for filgotinib. While there has always been concerns surrounding the Janus kinase (JAK) inhibitor’s safety class profile across the immune space, Gilead’s hopes to differentiate the drug as ‘the safest JAK’ due to its lower rate of adverse events from cross-trial comparisons is […]
Read more

Use of stem cells appears promising in restoring fertility in premature ovarian failure patients

The use of stem cells to “re-awaken” the ovaries in women with premature ovarian failure (POF) pave the way for novel treatments for this cause of infertility, says GlobalData, a leading data and analytics company. Despite their young age, POF patients face a difficult-to-treat infertility issue with limited treatment options and relatively poor fertility outcomes. In the randomized, prospective, pilot study, presented at this year’s European Society of Human Reproduction and Embryology (ESHRE) congress, follicular development was demonstrated in a […]
Read more

UK’s plans for significant revisions to outbreak control agencies has questionable timing amid 40,000 death toll, says GlobalData

Following the news that UK Health Secretary Matt Hancock has announced National Institution for Health Protection; Michael Breen, Director of Infectious Diseases at GlobalData, offers his view: “The COVID-19 pandemic has exposed both global and national inefficiencies in responding to the COVID-19 outbreak, and, in light of an estimate that there has been 40,000 deaths […]
Read more

India’s CMO market emerges as hotbed for global private equity investment, says GlobalData

India’s contract manufacturing organization (CMO) and pharma market has strongly attracted investment from global private equity firms in recent times, driven by favorable government policies and a thriving generic drugs market, says GlobalData, a leading data and analytics company. In July 2020, US-based Advent International agreed to acquire a controlling stake in RA Chem Pharma […]
Read more

COVID-19 disrupted clinical trials with suspended enrollment more likely to resume, says GlobalData

The number of total disrupted clinical trials has begun to fall since June, however, only trials that suspended enrollment have been on a downward trajectory, says GlobalData, a leading data and analytics company. Brooke Wilson, Associate Director, Trials Intelligence at GlobalData, comments: “Trials that had already initiated enrollment before the pandemic – having already chosen […]
Read more

COVID-19 is causing lower flu vaccination rates in the UK, says GlobalData

The UK has one of the highest flu vaccination rates in the world. However, the COVID-19 pandemic is increasing appointment times due to extra precautions needing to be taken to avoid COVID-19 contamination and reducing patients’ access to healthcare over fear of catching the disease. Therefore, despite the importance of vaccination during the pandemic, GlobalData […]
Read more
1 … 81 82 83 84 85 … 108